BridgeBio Pharma Inc
Change company Symbol lookup
Select an option...
BBIO BridgeBio Pharma Inc
HOSZY Haci Omer Sabanci Holding AS
FREJN Federal Home Loan Mortgage Corp
NXPL NextPlat Corp
$QCF E-MINI NASDAQ COMPOSITE SPOT FIX
CURI CuriosityStream Inc
AXDX Accelerate Diagnostics Inc
MS-I Morgan Stanley
TCRX TScan Therapeutics Inc
TRCK Track Group Inc
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

BridgeBio Pharma, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on discovering, creating, testing and delivering transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. The Company's pipeline of development programs ranges from early science to advanced clinical trials, which include Acoramidis (AG10), a small molecule stabilizer of transthyretin (TTR), that is in an ongoing Phase 3 clinical trial for the treatment of TTR amyloid cardiomyopathy (ATTR-CM); Low-dose infigratinib, a small molecule selective FGFR1-3 inhibitor that is in an ongoing Phase 2 clinical trial for the treatment of children with achondroplasia; Encaleret, a small molecule antagonist of the calcium sensing receptor (CaSR) for Autosomal Dominant Hypocalcemia Type 1 (ADH1); and BBP-418, an orally administered substrate replacement product candidate for the treatment of Limb-Girdle Muscular Dystrophy type 2I, and others.

Closing Price
$13.75
Day's Change
0.21 (1.55%)
Bid
--
Ask
--
B/A Size
--
Day's High
13.81
Day's Low
13.22
Volume
(Average)
Volume:
1,408,525

10-day average volume:
1,501,340
1,408,525
  • Prev Close
    13.54
  • Today's Open
    13.44
  • Day's Range
    13.22-13.81
  • Avg Vol (10-day)
    1.5M
  • Last (time)
    4:00p ET 05/26/23
  • Last (size)
    10
  • 52-Wk Range
    5.74 - 19.95
    LowHigh
  • (06/13/22 - 03/07/23)
    31.06%
  • 101.9%
  • Market Cap
    2.2B
  • Shares Outstanding
    160.5M
  • -2.83
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.7
  • 92.44
  • (% of float 05/15/23)
    11.31

Latest News

May 22, 2023
7:30 am ET
Globe Newswire
May 15, 2023
7:30 am ET
Globe Newswire
May 11, 2023
7:30 am ET
Globe Newswire
May 04, 2023
7:30 am ET
Globe Newswire
April 27, 2023
7:30 am ET
Globe Newswire
April 19, 2023
9:46 am ET
PR Newswire
6:49 am ET
MarketWatch
April 11, 2023
7:30 am ET
Globe Newswire
April 07, 2023
7:30 am ET
Globe Newswire
March 23, 2023
7:30 am ET
Globe Newswire
March 21, 2023
7:30 am ET
Globe Newswire
March 17, 2023
7:30 am ET
Globe Newswire
March 08, 2023
7:00 am ET
Globe Newswire
March 06, 2023
4:05 pm ET
Globe Newswire
11:06 am ET
MarketWatch
8:30 am ET
PR Newswire
8:26 am ET
MarketWatch
8:15 am ET
MarketWatch
7:00 am ET
Globe Newswire
March 03, 2023
7:30 am ET
Globe Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.